Accelerated approvals hit the target in precision oncology

被引：0
|
作者：
Vivek Subbiah
Lori J. Wirth
Razelle Kurzrock
Richard Pazdur
Julia A. Beaver
Harpreet Singh
Gautam U. Mehta
机构：
[1] The University of Texas MD Anderson Cancer Center,Harvard Medical School
[2] Massachusetts General Hospital,Oncology Center of Excellence
[3] Medical College of Wisconsin Cancer Center and Genome Science and Precision Medicine Center,Center for Drug Evaluation and Research
[4] US Food and Drug Administration,undefined
[5] US Food and Drug Administration,undefined
来源：
Nature Medicine | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1976 / 1979
页数：3
相关论文
共 50 条
  • [21] HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology
    Shrestha, Raunak
    Hodzic, Ermin
    Sauerwald, Thomas
    Dao, Phuong
    Wang, Kendric
    Yeung, Jake
    Anderson, Shawn
    Vandin, Fabio
    Haffari, Gholamreza
    Collins, Colin C.
    Sahinalp, S. Cenk
    GENOME RESEARCH, 2017, 27 (09) : 1573 - 1588
  • [22] Accelerated vs. regular approval: Lessons learned from US FDA oncology approvals.
    Leao, Ihid Carneiro
    Blumenthal, Gideon Michael
    Reaman, Gregory H.
    Pazdur, Richard
    Liu, Ke
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] US FDA-accelerated approvals and subsequent withdrawals: influence on Japanese clinical oncology practice guidelines
    Hakariya, Hayase
    Ozaki, Akihiko
    Tanimoto, Tetsuya
    INVESTIGATIONAL NEW DRUGS, 2025,
  • [24] Conflicting signals on US accelerated approvals
    Fox, JL
    NATURE BIOTECHNOLOGY, 2005, 23 (09) : 1027 - 1028
  • [25] Challenges in accelerated approvals for gene therapies
    Escandon, Rafael
    Lantos, John
    MOLECULAR THERAPY, 2023, 31 (09) : 2572 - 2574
  • [26] Conflicting signals on US accelerated approvals
    Jeffrey L Fox
    Nature Biotechnology, 2005, 23 : 1027 - 1028
  • [27] Biomarker use in oncology approvals in the US
    Dou, Yannan Nancy
    Grimstein, Christian
    Wang, Jian
    Mascaro, Jacques
    CANCER RESEARCH, 2024, 84 (06)
  • [28] Speeding Access to Precision Oncology Drugs: How Are We Doing With Biomarker-Driven Drug Approvals?
    Li, Tianhong
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (01): : 113 - 114
  • [29] FDA Drug Approvals Hit Record Levels in 2017
    Challener, Cynthia A.
    BIOPHARM INTERNATIONAL, 2018, 31 (01) : 12 - 14
  • [30] Molded optics - Molded glass aspheric optics hit the target for precision and cost
    Patton, Edward
    Stites, David
    Cahall, Scott
    LASER FOCUS WORLD, 2007, 43 (12): : 71 - 74
12345